← FDA Drug Approvals (Drugs@FDA)

TERIFLUNOMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2020-02-28

Drug application

FDA Application #

ANDA209702

Application type

Abbreviated New Drug Application (Generic)

Brand name

TERIFLUNOMIDE

Generic name

TERIFLUNOMIDE

Active ingredients

TERIFLUNOMIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

SOMERSET THERAPS LLC

Manufacturer

Mylan Pharmaceuticals Inc.

First approval

2020-02-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown